Fractyl Health is entering pivotal studies for a procedure that aims to be an ‘off ramp’ to GLP-1s and exploring how a one-time, ‘smart GLP-1’ gene therapy can Treat type 2 diabetes.

AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...

INTERVIEW: The enigmatic star talks to Adam White about sexuality, psychopaths and ‘Severance’ – and why Madonna and Sean ...

This is just one of a number of tactics used by biotech firms aimed at preventing the classic biotech pitfalls of a company collapsing because its lead product has failed, or because of a lack of ...

The test relies on a magnetic nanoparticle linked to fluorescent molecules to detect pancreatic cancer proteins.

There is a classic example in the drug discovery industry ... Also, it’s a lot cheaper to run a biotech in China than it is in the U.S., so you just saw this explosion of innovation in the ...

Eco-lovers in the UK can now be buried in the world's first 'living coffin' - which decomposes faster and is made out of ...

The bullish sentiment is expected to sustain with the VIX reaching a one-month low. Below are some trading ideas for the near ...

Products from Japan's Prossence to Korea's Sulwhasoo, Innisfree and Laneige, have had a big impact on global skincare habits, ...

AceLink is advancing a small-molecule treatment option for Fabry disease, which could provide a more convenient alternative ...

No doubt, “collagen skin care” is a buzzy phrase in the beauty world. Along with retinol and peptides, when collagen is on a ...